Getinge B, SE0000202624

Handelsbanken raises target for Getinge stock from SEK 240 to SEK 265

Published on 10/18/2026 at 13:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Third-quarter consensus sees SEK 8.48 billion sales and 14.05 percent adjusted EBITA. Handelsbanken sets SEK 265 for Getinge stock on October 13, 2026.

Analyst view and report schedule

  • Handelsbanken lifted its Getinge target from SEK 240.00 to SEK 265.00 on October 13, 2026.
  • Third-quarter consensus projects SEK 8.48 billion in sales and a 14.05 percent adjusted EBITA margin.
  • Getinge plans to release its third-quarter report on October 21, 2026, at 8:00 a.m. CEST.
Getinge AB (ISIN SE0000202624) wird hier als geometrisches Bauhaus-Poster mit Sektor-Kürzel MEDTECH und Herzschlaglinie dargestellt, Illustration mit AI erstellt.

Getinge stock (ISIN SE0000202624) enters its third-quarter report with consensus sales of SEK 8.48 billion and an adjusted EBITA margin of 14.05 percent. According to Inderes on October 16, 2026, the estimates came from 12 contributors ahead of the report.

Handelsbanken raised its target for Getinge from SEK 240.00 to SEK 265.00 and maintained a Hold rating on October 13, 2026, according to MarketScreener. The target change places valuation alongside the operating test that arrives with the next report.

Three dates shape the setup

On July 17, 2026, Getinge reported second-quarter revenue of SEK 8.381 billion and net income of SEK 841.0 million, compared with SEK 8.238 billion and SEK 524.0 million in the second quarter of 2025, according to Simply Wall St. On October 7, 2026, Getinge announced an October 21 reporting date at 8:00 a.m. CEST in an Getinge press release. On October 16, 2026, the consensus set third-quarter sales at SEK 8.48 billion and adjusted EBITA at SEK 1.185 billion.

What will the report test?

The central issue is whether sales can reach the SEK 8.48 billion median while adjusted EBITA reaches SEK 1.185 billion. The implied margin of 14.05 percent gives investors a precise operating benchmark, while the 12-contributor estimate provides a quantified comparison for the results release.

Dates and valuation frame

Getinge is scheduled to publish its third-quarter report on October 21, 2026, at 8:00 a.m. CEST, followed by a conference call at 10:00 a.m. CEST. The next annual report is listed for January 26, 2027, according to Affarsvarlden. The companys market capitalization stood at SEK 69.9 billion on October 16, 2026.

Report benchmarks come first

Getinge therefore reaches the reporting date with an analyst target of SEK 265.00, a sales median of SEK 8.48 billion and a margin benchmark of 14.05 percent. The next disclosed figures will determine whether the stronger second-quarter profitability continues into the third quarter.

The further course of trading is shown by the continuously updated real-time quote of Getinge B stock.

Getinge B stock facts

  • Company: Getinge AB (publ)
  • ISIN: SE0000202624
  • Ticker: GETI B
  • Sector / Industry: Healthcare / Medical Devices
  • Market capitalization: SEK 69.9 billion (as of October 16, 2026)
  • Next earnings date: October 21, 2026

Market context: Market report OMXS30.

More news and analyses on Getinge B stock

Disclaimer...
en | SE0000202624 | GETINGE B | boerse | 70353270 | bgmi